|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/55 | |
| A61K 31/436 | |||
| A61K 38/13 | |||
| A61K 31/439 | |||
| A61K 31/4427 | |||
| A61K 31/4985 | |||
| A61K 31/4439 | |||
| A61K 31/4995 | |||
| A61K 45/06 | |||
| A61P 27/02 | |||
| A61P 11/02 | |||
| A61P 25/02 | |||
| A61K 9/00 | |||
| A61K 9/08 |
| (11) | Patento numeris | 3209295 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15852340.7 |
| Europos patento paraiškos padavimo data | 2015-10-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/056273 |
| Data | 2015-10-19 |
| (87) | Numeris | WO 2016/064759 |
| Data | 2016-04-28 |
| (30) | Numeris | Data | Šalis |
| 201462066280 P | 2014-10-20 | US | |
| 201562100844 P | 2015-01-07 | US |
| (72) |
ACKERMANN, Douglas Michael, Jr., US
LOUDIN, James, US
MANDELL, Kenneth J., US
|
| (73) |
Oyster Point Pharma, Inc.,
202 Carnegie Center, Suite 109, Princeton, New Jersey 08540,
US
|
| (54) | METHODS OF TREATING OCULAR CONDITIONS |
| METHODS OF TREATING OCULAR CONDITIONS |